We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LDHAU
251
DELISTED
LDH Growth Corp I Units
LDHAU
$202K 0.03%
+20,000
New +$202K
GTPAU
252
DELISTED
Gores Technology Partners, Inc. Units
GTPAU
$200K 0.03%
+20,000
New +$203K
TMPOW
253
DELISTED
Tempo Automation Holdings, Inc. Warrant
TMPOW
$195K 0.03%
99,999
XENE icon
254
Xenon Pharmaceuticals
XENE
$6.21B
$186K 0.03%
+10,365
New +$176K
DSACW
255
DELISTED
Duddell Street Acquisition Corp. Warrant
DSACW
$180K 0.03%
149,999
DMYI.WS
256
DELISTED
dMY Technology Group, Inc. III Redeemable warrants, each whole warrant exercisable for one share of
DMYI.WS
$172K 0.03%
+74,998
New +$220K
ALUS.WS
257
DELISTED
Alussa Energy Acquisition Corp Warrants
ALUS.WS
$171K 0.03%
75,000
APGNW
258
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$169K 0.03%
+99,998
New +$203K
PDAC.WS
259
DELISTED
Peridot Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordina
PDAC.WS
$168K 0.03%
+99,999
New +$271K
LIDRW icon
260
AEye Inc Warrant
LIDRW
$46.7K
$164K 0.03%
+116,664
New +$262K
SNPR.WS
261
DELISTED
Tortoise Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary shar
SNPR.WS
$163K 0.03%
49,999
ETWO.WS
262
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$161K 0.02%
+74,999
New +$150K
CRHC.WS
263
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$160K 0.02%
133,331
ETACW
264
DELISTED
E.Merge Technology Acquisition Corp. Warrant
ETACW
$158K 0.02%
166,665
TMCWW
265
TMC The Metals Company Warrants
TMCWW
$971K
$157K 0.02%
174,999
LFTRW
266
DELISTED
Lefteris Acquisition Corp. Warrant
LFTRW
$156K 0.02%
+133,332
New +$274K
MYPSW
267
DELISTED
PLAYSTUDIOS Inc Warrant
MYPSW
$152K 0.02%
99,999
SRSAW
268
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$150K 0.02%
99,998
CFIVW
269
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$147K 0.02%
+166,666
New +$210K
DEH.WS
270
DELISTED
D8 Holdings Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exer
DEH.WS
$144K 0.02%
124,999
ORGNW
271
DELISTED
Origin Materials Inc Warrants
ORGNW
$143K 0.02%
83,332
CHAQ.WS
272
DELISTED
Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
CHAQ.WS
$141K 0.02%
150,000
TLMDW
273
DELISTED
SOC Telemed, Inc. Warrants
TLMDW
$137K 0.02%
150,000
SPRQ.WS
274
DELISTED
Spartan Acquisition Corp. II Warrants, exercisable for one share of Class A Common Stock
SPRQ.WS
$137K 0.02%
+74,999
New +$173K
ALTUW
275
DELISTED
Altitude Acquisition Corp Warrant
ALTUW
$136K 0.02%
+79,999
New +$190K

Similar funds

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.